Vera M Poort
Overview
Explore the profile of Vera M Poort including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derks L, van Leeuwen A, Steemers A, Trabut L, van Roosmalen M, Poort V, et al.
STAR Protoc
. 2024 Dec;
6(1):103499.
PMID: 39709610
The study of somatic mutations in single cells provides insights into aging and carcinogenesis, which is complicated by the dependency on whole-genome amplification (WGA). Here, we describe a detailed workflow...
2.
Poort V, Hagelaar R, van Roosmalen M, Trabut L, Buijs-Gladdines J, van Wijk B, et al.
Cancer Res
. 2024 Jun;
84(16):2720-2733.
PMID: 38885294
Leukemia is characterized by oncogenic lesions that result in a block of differentiation, whereas phenotypic plasticity is retained. A better understanding of how these two phenomena arise during leukemogenesis in...
3.
Cordo V, Meijer M, Hagelaar R, de Goeij-de Haas R, Poort V, Henneman A, et al.
Nat Commun
. 2022 Feb;
13(1):1048.
PMID: 35217681
Protein kinase inhibitors are amongst the most successful cancer treatments, but targetable kinases activated by genomic abnormalities are rare in T cell acute lymphoblastic leukemia. Nevertheless, kinases can be activated...
4.
Kroeze E, Loeffen J, Poort V, Meijerink J
Blood Adv
. 2020 Jul;
4(14):3466-3473.
PMID: 32722786
T-cell lymphoblastic lymphoma (T-LBL) and lymphoblastic leukemia (T-ALL) represent malignancies that arise from the transformation of immature precursor T cells. Similarities in T-LBL and T-ALL have raised the question whether...